Nu Skin/NUS

$12.39

0.16%
-
1D1W1MYTD1YMAX

About Nu Skin

Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Company’s Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.

Ticker

NUS

Sector

Consumer Non-Cyclicals

Trading on

NYSE

Industry

Major Drugs

CEO

Steven Lund

Employees

3,700

Headquarters

Provo, United States

Nu Skin Metrics

BasicAdvanced
$609.85M
Market cap
76.09
P/E ratio
$0.16
EPS
1.10
Beta
$1.56
Dividend rate
1.94%
Dividend yield

What the Analysts think about Nu Skin

Analyst Ratings

Majority rating from 4 analysts.
Hold

Price Targets

Average projection from 4 analysts.
63.44% upside
High $25.00
Low $17.00
$12.39
Current price
$20.25
Average price target

Nu Skin Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
1.47% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$488.6M
-2.03%
Net income
$7.2M
-119.51%
Profit margin
1.47%
-119.89%

Nu Skin Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 29.94%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.37
$0.54
$0.56
$0.37
-
Expected
$0.33
$0.53
$0.62
$0.28
$0.05
Surprise
12.21%
1.27%
-10.26%
29.94%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Nu Skin stock

Buy or sell Nu Skin stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing